Avacopan 10mg capsules
NHS hospitals in England used £64,906,072 of indicative cost of Avacopan 10mg capsules in the 12 months to April 2026, about 0.3% of all hospital medicines spend. That is up 29.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Avacopan 10mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Avacopan 10mg capsules most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Imperial College Healthcare Nhs Trust | £4,649,983 |
| Cambridge Univ Hosp Nhs Foundation Trust | £3,705,414 |
| Derby Teaching Hospitals Nhs Found Trust | £3,583,976 |
| Manchester University Nhs Ft | £2,893,903 |
| Lancashire T/Ing Hsp Nhs Foundation Trus | £2,777,180 |
| Leeds Teaching Hpls Nhs Trust | £2,328,413 |
| Oxford University Hospitals Nhs Ft | £2,188,296 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,983,885 |
| Barts Health Nhs Trust | £1,841,919 |
| University Hpls Of Leicester Nhs Trust | £1,803,084 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.